CompletedNCT00004738
Genetic Analysis of the Chiari I Malformation
Studying OBSOLETE: Primary syringomyelia/hydromyelia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- John D Heiss, M.D.National Institute of Neurological Disorders and Stroke (NINDS)
- Enrollment
- 152 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2001
Study locations (2)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Kazan State Medical University, Kazan', Russia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004738 on ClinicalTrials.govOther trials for OBSOLETE: Primary syringomyelia/hydromyelia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07295067Extracellular Vesicles for the Treatment of SyringomyeliaXuanwu Hospital, Beijing
- ACTIVE NOT RECRUITINGNCT01150708A Prospective Natural History Study of Patients With SyringomyeliaNational Institute of Neurological Disorders and Stroke (NINDS)
See all trials for OBSOLETE: Primary syringomyelia/hydromyelia →